JPRN-UMIN000039915尚未招募未知
sefulluness of single inhalaer treatment with long acting muscarinic antagonist, long acting beta agosit, and inhaled corticosteroid in symptomatic patients with symptomatic chronic obstructive pulmonary disease without asthma and exacerbation - Triple therapy for symptomatic COPD without asthma and exacerbation
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Asmptomatic COPD patients, asthma COPD overlap patients, COPD patients with exacerbation history, COPD patients with malignancy, COPD patients with other serious medical conditions, and COPD patients who were judged to be unsuitable for this study by attending physicians
研究者
相似试验
招募中
4 期
Efficacy and safety of once-daily single-Inhaler TRiple (Trelegy Ellipta) therApy for Japanese with mild to moderate COPD in Kyushu (TRACK study)Mild to moderate COPDCOPDJPRN-jRCTs071210124Hiromasa Inoue668
招募中
不适用
Efficacy and safety of once-daily single-Inhaler TRiple(Trelegy Ellipta) therApy for Japanese with mild to moderate COPD in KyushuChronic obstructive pulmonary disease (COPD)JPRN-UMIN000046812Kagoshima university668
进行中（未招募）
不适用
Efficacy of Symptom-driven treatment with inhaled budesonide/formoterol versus fixed dose fluticasone/salmeterol in COPDChronic obstructive pulmonary disease (COPD)EUCTR2014-001563-12-NLniversity Medical Center Groningen
已完成
4 期
Efficacy of Single inhaler Maintenance And Reliever Therapy (SMART) with Spiromax® budesonide/formoterol versus fixed dose treatment with Diskus® fluticasone/salmeterol in COPDChronic obstructive pulmonary diseaseCOPD10006436NL-OMON44539niversitair Medisch Centrum Groningen260
招募中
不适用
The Real World Effectiveness of Single Inhaler Triple Treatment through Assorted Respiratory Outcomes when Switched from Multiple Inhaler Triple Therapies (RESTART study)KCT0007752Gyeongsang National University Hospital107